Tag: CBT > Cannabis Schedule: Page 7

Legislation and Regulation

Boston … ‘280E THC’ Party? MariMed Takes it Back to 1773

The Massachusetts-based multistate cannabis operator protested unfair cannabis industry tax laws that have hurt businesses and workers alike.

July 13, 2023

Cannabis Rescheduling

New Coalition Launches Campaign in Support of Cannabis Scheduling Reform

As the Biden Administration actively reviews the classification of cannabis under the Controlled Substances Act, a diverse group of cannabis companies and organizations is partnering with scientific and legal experts to launch the Coalition for Cannabis Scheduling Reform.

June 6, 2023

The Last Word

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

March 13, 2023

Cannabis Rescheduling

US Representative Reintroduces Legislation to Reschedule Cannabis

Rep. Greg Steube has reintroduced the Marijuana 1-to-3 Act, which would reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.

February 1, 2023

Hemp Research

Risky Research

January 5, 2023

Legislation and Regulation

US House Members Release Memo on Benefits of Cannabis Decriminalization, Descheduling, Propose Reforms

The U.S. House Oversight Committee’s Subcommittee on Civil Rights and Civil Liberties released the joint memo ahead of a Nov. 15 hearing on cannabis.

November 14, 2022

Legislation and Regulation

To Reschedule or Deschedule? Plant-Touching Businesses Weigh In

Owners and operators of cannabis companies across the U.S. say they would like to see cannabis completely descheduled as a result of President Joe Biden’s order to review cannabis’s status under the Controlled Substances Act.

November 7, 2022

2022 Election and Cannabis

Will Cannabis Policy Change?

Past reviews of cannabis’s Schedule I classification in the Controlled Substances Act—the most recent of which took five years and ended in 2016—have never moved the needle with the Drug Enforcement Agency. Many wonder if this time will be different with the directive coming from the president.

October 26, 2022

Legislation and Regulation

Biden's Order to Review Cannabis 'Truly Historic,' But What's at Stake?

Many industry experts agree removing cannabis from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster' for the state-legal industry.

October 26, 2022

Interviews & Opinion

Study Shows Two-Thirds of American Adults Support Biden’s Cannabis Policy Reform Plan

The poll found that nearly three-quarters of respondents support changing how cannabis is classified under federal law and removing it as a Schedule I drug.

October 21, 2022

Legislation and Regulation

Judge Orders Nevada Board of Pharmacy to Remove Cannabis from State’s List of Schedule I Substances

Clark County District Judge Joe Hardy’s Sept. 14 ruling stems from a lawsuit filed by the ACLU of Nevada.

September 19, 2022

Legislation and Regulation

U.S. House Passes MORE Act, Again

Voting 220-204, almost entirely along party lines, lawmakers passed the broad cannabis reform legislation for a second time in the lower chamber.

April 1, 2022